A window into the future: Understanding and predicting longevity podcast

Listen to our podcast. Daniel Ryan, Head of Research & Development for Life & Health and Costas Yiasoumi, Head of Longevity Solutions, discuss the new Swiss Re longevity report.

The good news that people are living longer has brought with it substantial financial problems throughout much of the world. One of the reasons behind the funding difficulties is that historical projections of future longevity have failed to take account of important developments in medicine and society. "A window into the future: Understanding and predicting longevity" analyses how improved models for assessing life expectancy could play a part in the overall solution.

Report author Daniel Ryan and Head of Longevity Solutions Costas Yiasoumi discuss the content of this report and the implications for pension plans, insurers and governments.

Download podcast


Funding longer lives

Medical advances have helped increase life expectancy, but with this good news comes challenges in retirement financing. Swiss Re believes governments, insurers and pension funds should work together...

Read the whole story

Insurers reduce risk in their...

Products protecting insurers and pension funds against the financial risk of retirees living longer than previously expected are becoming more common – and primary insurers are leading the way.

Read the whole story


Write a comment

Comment Policy
(All fields marked with * are mandatory)

In our ongoing efforts to improve the quality and relevance of our publications, we would like to know more about you.

*mandatory

Interested in subscribing to our content? Visit our subscription page

Remember me

We use cookies to gather information that will help us provide the best possible service. By using this site, you are accepting our cookie policy.

In our ongoing efforts to improve the quality and relevance of our publications, we would like to know more about you.

* required fields

Interested in subscribing to our content? Visit our subscription page.

Close